In order to assess whether HMGA1 and HMGA2 may serve as prognostic factors in EEC, we evaluated their mRNA and protein expression profile in EEC tumors ranging from stage IA to stage IV and correlated the clinicopathological features with the molecular findings. Here, HMGA2 is linked to exstrophy-epispadias complex.